InMed Pharmaceuticals (INM) Invested Capital: 2021-2025
Historic Invested Capital for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $11.6 million.
- InMed Pharmaceuticals' Invested Capital rose 38.06% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 38.06%. This contributed to the annual value of $13.4 million for FY2025, which is 45.93% up from last year.
- InMed Pharmaceuticals' Invested Capital amounted to $11.6 million in Q3 2025, which was down 13.72% from $13.4 million recorded in Q2 2025.
- In the past 5 years, InMed Pharmaceuticals' Invested Capital ranged from a high of $15.2 million in Q3 2021 and a low of -$9.6 million during Q3 2023.
- Its 3-year average for Invested Capital is $8.6 million, with a median of $11.1 million in 2024.
- Per our database at Business Quant, InMed Pharmaceuticals' Invested Capital slumped by 187.01% in 2023 and then spiked by 187.65% in 2024.
- Quarterly analysis of 5 years shows InMed Pharmaceuticals' Invested Capital stood at $14.2 million in 2021, then climbed by 0.77% to $14.3 million in 2022, then fell by 10.90% to $12.8 million in 2023, then slumped by 51.60% to $6.2 million in 2024, then surged by 38.06% to $11.6 million in 2025.
- Its Invested Capital stands at $11.6 million for Q3 2025, versus $13.4 million for Q2 2025 and $7.0 million for Q1 2025.